This inventor holds 1 USPTO granted patent. Top assignees: Anges, Inc., Genedesign, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Tetsuo Miyake: Innovator in Oligonucleotide Technology
Introduction
Tetsuo Miyake is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide decoys. His innovative work has led to the filing of a patent that showcases his expertise and creativity.
Latest Patents
Miyake holds a patent for a chimeric decoy, which is a double-stranded oligonucleotide that includes two transcription factor-binding sites while maintaining a small size. This double-stranded oligonucleotide decoy demonstrates binding affinities for two transcription factors. It consists of a first binding site for a first transcription factor and a second binding site for a second transcription factor. The first strand includes the sense strand of the first binding site, while the second strand includes the sense strand of the second binding site, which are hybridized to form a double strand. This innovative design allows for effective binding and interaction with transcription factors.
Career Highlights
Throughout his career, Tetsuo Miyake has worked with several prominent companies in the biotechnology sector. Notable among these are Anges, Inc. and Genedesign, Inc. His work in these organizations has contributed to advancements in genetic research and therapeutic applications.
Collaborations
Miyake has collaborated with esteemed colleagues, including Ryuichi Morishita and Takashi Miyake. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tetsuo Miyake's contributions to the field of biotechnology, particularly through his patented chimeric decoy, highlight his role as an influential inventor. His work continues to impact the scientific community and advance our understanding of genetic interactions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile